Literature DB >> 24135287

The role of chaplains in end-of-life decision making: results of a pilot survey.

Stephanie Clemm1, Ralf J Jox1, Gian Domenico Borasio2, Traugott Roser1.   

Abstract

OBJECTIVE: The overall aim of this study was to discover how chaplains assess their role within ethically complex end-of-life decisions.
METHODS: A questionnaire was sent to 256 chaplains working for German health care institutions. Questions about their role and satisfaction as well as demographic data were collected, which included information about the chaplains' integration within multi-professional teams.
RESULTS: The response rate was 59%, 141 questionnaires were analyzed. Respondents reported being confronted with decisions concerning the limitation of life-sustaining treatment on average two to three times per month. Nearly 74% were satisfied with the decisions made within these situations. However, only 48% were satisfied with the communication process. Whenever chaplains were integrated within a multi-professional team there was a significantly higher satisfaction with both: the decisions made (p = 0.000) and the communication process (p = 0.000). Significance of the results: Although the results of this study show a relatively high satisfaction among surveyed chaplains with regard to the outcome of decisions, one of the major problems seems to reside in the communication process. A clear integration of chaplains within multi-professional teams (such as palliative care teams) appears to increase the satisfaction with the communication in ethically critical situations.

Keywords:  Palliative care

Mesh:

Year:  2013        PMID: 24135287     DOI: 10.1017/S1478951513000266

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  1 in total

1.  Experiences of Dutch general practitioners and district nurses with involving care services and facilities in palliative care: a mixed methods study.

Authors:  Ian Koper; H Roeline W Pasman; Bregje D Onwuteaka-Philipsen
Journal:  BMC Health Serv Res       Date:  2018-11-08       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.